Patrick Donnelly
Stock Analyst at Citigroup
(3.69)
# 745
Out of 4,960 analysts
339
Total ratings
51.91%
Success rate
5.99%
Average return
Main Sectors:
Stocks Rated by Patrick Donnelly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MTD Mettler-Toledo International | Maintains: Buy | $1,400 → $1,600 | $1,321.45 | +21.08% | 14 | Aug 21, 2025 | |
| ICLR ICON Public Limited Company | Downgrades: Neutral | $225 → $200 | $175.83 | +13.75% | 10 | Aug 21, 2025 | |
| TECH Bio-Techne | Upgrades: Buy | $55 → $70 | $57.09 | +22.61% | 12 | Aug 21, 2025 | |
| CAI Caris Life Sciences | Maintains: Buy | $34 → $42 | $39.30 | +6.87% | 2 | Aug 13, 2025 | |
| QDEL QuidelOrtho | Maintains: Buy | $50 → $40 | $27.90 | +43.37% | 5 | Aug 6, 2025 | |
| BRKR Bruker | Maintains: Neutral | $40 → $38 | $35.54 | +6.92% | 17 | Aug 4, 2025 | |
| CRL Charles River Laboratories International | Upgrades: Buy | $150 → $200 | $161.84 | +23.58% | 21 | Jul 9, 2025 | |
| HOLX Hologic | Upgrades: Buy | $60 → $80 | $68.26 | +17.20% | 15 | Jul 9, 2025 | |
| ILMN Illumina | Downgrades: Sell | $85 → $80 | $101.80 | -21.41% | 17 | Jul 9, 2025 | |
| BIO Bio-Rad Laboratories | Maintains: Buy | $400 → $350 | $303.82 | +15.20% | 15 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $400 → $350 | $288.55 | +21.30% | 15 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $15 | $14.30 | +4.90% | 12 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $22 → $18 | $13.27 | +35.64% | 8 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $225 → $210 | $191.15 | +9.86% | 10 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $650 → $570 | $499.99 | +14.00% | 19 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $185 | $180.23 | +2.65% | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $265 | $211.80 | +25.12% | 12 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $30 → $23 | $8.34 | +175.94% | 4 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $20 | $16.43 | +21.73% | 3 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $75 | $47.47 | +57.99% | 13 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $165 | $121.63 | +35.66% | 26 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $45 | $61.40 | -26.71% | 9 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $28 | $22.62 | +23.78% | 4 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $145 | $94.15 | +54.01% | 1 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $62 | $49.74 | +24.25% | 13 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $265 → $300 | $302.19 | -0.72% | 24 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $3.00 | +200.50% | 6 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.75 → $2.75 | $2.38 | +15.55% | 4 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $250 → $260 | $278.18 | -6.54% | 11 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $6 | $4.83 | +24.22% | 4 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $28 → $32 | $6.02 | +431.56% | 2 | Nov 30, 2018 |
Mettler-Toledo International
Aug 21, 2025
Maintains: Buy
Price Target: $1,400 → $1,600
Current: $1,321.45
Upside: +21.08%
ICON Public Limited Company
Aug 21, 2025
Downgrades: Neutral
Price Target: $225 → $200
Current: $175.83
Upside: +13.75%
Bio-Techne
Aug 21, 2025
Upgrades: Buy
Price Target: $55 → $70
Current: $57.09
Upside: +22.61%
Caris Life Sciences
Aug 13, 2025
Maintains: Buy
Price Target: $34 → $42
Current: $39.30
Upside: +6.87%
QuidelOrtho
Aug 6, 2025
Maintains: Buy
Price Target: $50 → $40
Current: $27.90
Upside: +43.37%
Bruker
Aug 4, 2025
Maintains: Neutral
Price Target: $40 → $38
Current: $35.54
Upside: +6.92%
Charles River Laboratories International
Jul 9, 2025
Upgrades: Buy
Price Target: $150 → $200
Current: $161.84
Upside: +23.58%
Hologic
Jul 9, 2025
Upgrades: Buy
Price Target: $60 → $80
Current: $68.26
Upside: +17.20%
Illumina
Jul 9, 2025
Downgrades: Sell
Price Target: $85 → $80
Current: $101.80
Upside: -21.41%
Bio-Rad Laboratories
May 2, 2025
Maintains: Buy
Price Target: $400 → $350
Current: $303.82
Upside: +15.20%
May 2, 2025
Maintains: Buy
Price Target: $400 → $350
Current: $288.55
Upside: +21.30%
Mar 4, 2025
Maintains: Buy
Price Target: $20 → $15
Current: $14.30
Upside: +4.90%
Mar 4, 2025
Maintains: Neutral
Price Target: $22 → $18
Current: $13.27
Upside: +35.64%
Mar 4, 2025
Maintains: Neutral
Price Target: $225 → $210
Current: $191.15
Upside: +9.86%
Mar 4, 2025
Maintains: Neutral
Price Target: $650 → $570
Current: $499.99
Upside: +14.00%
Mar 4, 2025
Downgrades: Neutral
Price Target: $185
Current: $180.23
Upside: +2.65%
Jan 30, 2025
Maintains: Buy
Price Target: $285 → $265
Current: $211.80
Upside: +25.12%
Dec 11, 2024
Downgrades: Neutral
Price Target: $30 → $23
Current: $8.34
Upside: +175.94%
Nov 6, 2024
Maintains: Buy
Price Target: $18 → $20
Current: $16.43
Upside: +21.73%
Nov 6, 2024
Maintains: Buy
Price Target: $80 → $75
Current: $47.47
Upside: +57.99%
Aug 22, 2024
Maintains: Buy
Price Target: $150 → $165
Current: $121.63
Upside: +35.66%
Aug 8, 2024
Maintains: Buy
Price Target: $40 → $45
Current: $61.40
Upside: -26.71%
Aug 7, 2024
Maintains: Buy
Price Target: $30 → $28
Current: $22.62
Upside: +23.78%
Jul 30, 2024
Maintains: Buy
Price Target: $135 → $145
Current: $94.15
Upside: +54.01%
Feb 8, 2024
Maintains: Buy
Price Target: $64 → $62
Current: $49.74
Upside: +24.25%
Dec 11, 2023
Maintains: Neutral
Price Target: $265 → $300
Current: $302.19
Upside: -0.72%
Dec 11, 2023
Maintains: Buy
Price Target: $7 → $9
Current: $3.00
Upside: +200.50%
Aug 10, 2023
Maintains: Neutral
Price Target: $3.75 → $2.75
Current: $2.38
Upside: +15.55%
Feb 17, 2023
Maintains: Neutral
Price Target: $250 → $260
Current: $278.18
Upside: -6.54%
Nov 3, 2022
Maintains: Buy
Price Target: $8 → $6
Current: $4.83
Upside: +24.22%
Nov 30, 2018
Upgrades: Neutral
Price Target: $28 → $32
Current: $6.02
Upside: +431.56%